Liver Lineup: Advances in MASH, PSC, and PBC Care at EASL 2025

In this episode of Liver Lineup: Updates & Unfiltered Insights, hosts Kimberly Brown, MD, a professor of Medicine at Michigan State University and Wayne State University, associate medical director of the Henry Ford Hospital Transplant Institute, and medical director of Transplant Outreach Services at Henry Ford Hospital, and Nancy Reau, MD, a professor of internal medicine, the Richard B. Capps Chair of Hepatology, associate director of solid organ transplantation, and the section chief of hepatology at Rush University Medical Center, continue their discussion on notable abstracts presented at the 2025 European Association for the Study of the Liver (EASL) Congress.

If you haven't already, be sure to check out part 1 here!

Key Episode Timestamps

0:00:00 LITMUS Study

0:05:47 Norursodeoxycholic Acid in PSC

0:10:12 GLOBE Score for PBC

0:15:11 Conclusion

Arbutus, and VIR. Relevant disclosures for Brown include Mallinckrodt Pharmaceuticals, Gilead, Salix, Intercept, Ipsen, and Madrigal.